Indefinite Delivery Contract HHSN261201000071I

Award Date 9/3/10
Last Date to Order 9/30/14
Ultimate Awardee
Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract, valued at $236,000.00, is part of the NCI Cancer Genome Atlas (TCGA) Program and aims to procure tissue samples and data from various cancer types for the TCGA's comprehensive genomic characterization efforts. The contract was awarded in August...
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to the British Columbia Cancer Agency Branch, a Canadian non-profit organization, to procure tissue samples and data from various cancer types to support the NCI's Cancer Genome Atlas (TCGA) program. The $16,000 firm fixed-price delivery order was issued on September 20, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase contract, which does not have a set-aside designation....
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $550,000 single-award contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master contract and aims to procure tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. Under a $488,000 delivery order, Sloan-Kettering Institute for Cancer Research, a...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract has a total ceiling value of $2,712,155.00 and does not have a set-aside designation. The contract consists of three firm-fixed-price delivery orders with a combined total value of $2,259,118.07. The...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $178,230 firm fixed-price delivery order is for the recovery and delivery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is part of the agency's efforts to characterize the genomic changes in cancer....
This federal Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Singapore Health Services PTE LTD (Singhealth) under the NCI Cancer Genome Atlas Program Tissue Purchase master contract. The contract, valued at $200,000.00, is for the delivery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the American Recovery and Reinvestment Act (ARRA)...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson). The contract supports the collection of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program, which aims to comprehensively characterize the genomic changes associated with different cancer types. As a leading cancer research institution, MD Anderson...
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to Wielkopolskie Centrum Onkologii IM Marii Sklodowskiej Curie, also known as Centrum Onkologii, to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract, valued at $420,000, is a firm fixed price award and is not set aside for any special designation. It was issued under the NCI Cancer Genome Atlas Program Tissue...
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to The Medical College of Wisconsin, Inc. (MCW) under an indefinite delivery contract for the NCI Cancer Genome Atlas Program Tissue Purchase. The $64,452.68 order is for the recovery and delivery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is funded through the American Recovery and Reinvestment Act (ARRA). MCW, a private medical school...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Cedars-Sinai Medical Center, a nonprofit hospital and academic medical center located in Los Angeles. The $22,113 contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the NCI's efforts related to the American Recovery and Reinvestment Act (ARRA)....

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian federal agency, to the Melanoma Institute Australia. The $192,500 firm fixed-price delivery order contract, part of the NCI's Cancer Genome Atlas (TCGA) program, involves the collection of tissue samples and data from various types of cancer. This work was funded under the American Recovery and Reinvestment Act (ARRA) and does not have a set-aside designation. The contract's period of performance runs from the award date of September 17, 2010 through the ultimate completion date of September 30, 2014, with performance taking place in Australia. The contract is a task order under the broader NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery vehicle.

Generated 4/2/25, 9:48 AM